| Net Cash Provided by (Used in) Operating Activities |
$375,235 |
USD |
-381% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$147,629 |
USD |
-28% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$315,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
4,249,090 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$153,540 |
USD |
37% |
Q3 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$153,540 |
USD |
37% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
$453,934 |
USD |
|
Q2 2024 |
Q3 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |